Use of copper chelating tetraamines for the treatment of cardiovascular disease and heart failure
CA 2828595 C · Owner: Philera New Zealand Limited · Inventors: Cooper, Garth James Smith; Baker, John Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of improving tissue repair in a mammalian patient of damaged tissue selected from that of the myocardium, the vascular tree and organs dependent on , the vascular tree, said method comprising or including the step of subjected the , patient to, and/or administering to the patient an agent or agents effective , in , lowering the copper values content of the patient's body sufficient to improve tissue repair.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 10, 2003 and granted November 28, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.